16-2071868-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_000548.5(TSC2):​c.2031C>T​(p.Pro677Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00588 in 1,593,286 control chromosomes in the GnomAD database, including 37 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. P677P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0034 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0061 ( 36 hom. )

Consequence

TSC2
NM_000548.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:25O:1

Conservation

PhyloP100: -1.64

Publications

6 publications found
Variant links:
Genes affected
TSC2 (HGNC:12363): (TSC complex subunit 2) This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
TSC2 Gene-Disease associations (from GenCC):
  • tuberous sclerosis
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • tuberous sclerosis 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Ambry Genetics
  • lymphangioleiomyomatosis
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • tuberous sclerosis complex
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 16-2071868-C-T is Benign according to our data. Variant chr16-2071868-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 49616.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.63 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00341 (519/152344) while in subpopulation NFE AF = 0.00637 (433/68022). AF 95% confidence interval is 0.00587. There are 1 homozygotes in GnomAd4. There are 235 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 519 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000548.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TSC2
NM_000548.5
MANE Select
c.2031C>Tp.Pro677Pro
synonymous
Exon 19 of 42NP_000539.2P49815-1
TSC2
NM_001406663.1
c.2031C>Tp.Pro677Pro
synonymous
Exon 19 of 42NP_001393592.1A0A2R8Y6C9
TSC2
NM_001114382.3
c.2031C>Tp.Pro677Pro
synonymous
Exon 19 of 41NP_001107854.1P49815-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TSC2
ENST00000219476.9
TSL:5 MANE Select
c.2031C>Tp.Pro677Pro
synonymous
Exon 19 of 42ENSP00000219476.3P49815-1
TSC2
ENST00000350773.9
TSL:1
c.2031C>Tp.Pro677Pro
synonymous
Exon 19 of 41ENSP00000344383.4P49815-4
TSC2
ENST00000401874.7
TSL:1
c.2031C>Tp.Pro677Pro
synonymous
Exon 19 of 40ENSP00000384468.2P49815-5

Frequencies

GnomAD3 genomes
AF:
0.00341
AC:
519
AN:
152226
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00123
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00144
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000659
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00636
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00255
AC:
534
AN:
209016
AF XY:
0.00254
show subpopulations
Gnomad AFR exome
AF:
0.00103
Gnomad AMR exome
AF:
0.00173
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000187
Gnomad FIN exome
AF:
0.000550
Gnomad NFE exome
AF:
0.00494
Gnomad OTH exome
AF:
0.00171
GnomAD4 exome
AF:
0.00615
AC:
8856
AN:
1440942
Hom.:
36
Cov.:
33
AF XY:
0.00585
AC XY:
4184
AN XY:
715160
show subpopulations
African (AFR)
AF:
0.00100
AC:
33
AN:
32996
American (AMR)
AF:
0.00181
AC:
77
AN:
42490
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25704
East Asian (EAS)
AF:
0.0000259
AC:
1
AN:
38554
South Asian (SAS)
AF:
0.000108
AC:
9
AN:
83228
European-Finnish (FIN)
AF:
0.000637
AC:
32
AN:
50226
Middle Eastern (MID)
AF:
0.000176
AC:
1
AN:
5686
European-Non Finnish (NFE)
AF:
0.00769
AC:
8477
AN:
1102574
Other (OTH)
AF:
0.00380
AC:
226
AN:
59484
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
558
1117
1675
2234
2792
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
354
708
1062
1416
1770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00341
AC:
519
AN:
152344
Hom.:
1
Cov.:
33
AF XY:
0.00315
AC XY:
235
AN XY:
74500
show subpopulations
African (AFR)
AF:
0.00123
AC:
51
AN:
41582
American (AMR)
AF:
0.00144
AC:
22
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.000659
AC:
7
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00637
AC:
433
AN:
68022
Other (OTH)
AF:
0.00284
AC:
6
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.521
Heterozygous variant carriers
0
29
58
88
117
146
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00415
Hom.:
2
Bravo
AF:
0.00317

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
11
not specified (11)
-
-
5
not provided (5)
-
-
3
Tuberous sclerosis 2 (3)
-
-
3
Tuberous sclerosis syndrome (4)
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
-
1
Tuberous sclerosis syndrome;C0349649:Lung lymphangioleiomyomatosis (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
0.40
DANN
Benign
0.60
PhyloP100
-1.6
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs45517208; hg19: chr16-2121869; COSMIC: COSV104587081; API